gastroesophageal%20reflux%20disease
GASTROESOPHAGEAL REFLUX DISEASE
Treatment Guideline Chart
Gastroesophageal reflux disease is a condition which results from the recurrent backflow of gastric contents into the esophagus and adjacent structures causing troublesome symptoms and/or tissue injury.
It is produced by various mechanisms such as frequent occurrence of transient relaxation of the lower esophageal sphincter or pressure abnormalities in the lower esophageal sphincter (which can be caused by hormonal and neural mediators, food, drugs and patient lifestyle).
Typical symptoms are acid regurgitation and heartburn.
Acid regurgitation is the perception of flow of refluxed gastric contents into the mouth or hypopharynx.
Heartburn is the burning sensation in the retrosternal region.

Gastroesophageal Reflux Disease References

  1. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr;19(4):357-367. PMID: 15012771
  2. DeVault KR, Castell DO, American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005 Jan;100(1):190-200. PMID: 15654800
  3. Dent J, Jones R, Kahrilas P, et al. Management of gastro-esophageal reflux disease in general practice. BMJ. 2001 Feb;322(7282):344-347. PMID: 11159660
  4. Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol. 2005 Jan;19(1):15-35. PMID: 15685294
  5. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-328. http://gi.org/guideline/diagnosis-and-managemen-of-gastroesophageal-reflux-disease/. Accessed 18 Jul 2013. PMID: 23419381
  6. Vakil N, van Zanten SV, Kahrilas P, et al; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-1920. PMID: 16928254
  7. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  8. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  9. Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel Veterans Health Administration Department of Veterans Affairs. VHA/DoD clinical practice guideline for the management of adults with gastroesophageal reflux disease in primary care practice. http://www.guideline.gov/. Mar 2003.
  10. New Zealand Guidelines Group. Management of dyspepsia and heartburn: evidence-based practice guideline. Ministry of Health. http://www.health.govt.nz/. Jun 2004.
  11. MedWormhttp://www.medworm.com/rss/search.php?qu=GORD+%28%2B%28GERD+acid+gastroesophageal+gastrooesophageal+%22gastro-oesophageal%22+%22gastro+oesophageal%22+%22gastro+esophageal%22+%22gastro-esophageal%22%29+%2Breflux%29&kid=156386&t=Acid+Reflux&f=c&r=Any&news=1http://www.medworm.com/rss/medicalfeeds/conditions/Acid-Reflux-News.xml
  12. Poh J. Restrictions on the use of metoclopramide-containing products. Health Sciences Authority (HSA). http://www.hsa.gov.sg. 21 Sep 2016. Accessed 14 Mar 2019.
  13. Sollano JD, Romano RP, Ibanez-Guzman L, et al. Clinical practice guidelines on the diagnosis and treatment of gastroesophageal reflux disease (GERD). Philippine Journal of Internal Medicine. 2015 Jul-Sep;53(3):1-17. http://www.pcp.org.ph/. Accessed 02 Oct 2015
  14. Hunt R, Armstrong D, Katelaris P, et al. GERD. Global perspective on gastroesophageal reflux disease. World Gastroenterology Organisation (WGO). http://www.worldgastroenterology.org/. Oct 2015. Accessed 06 May 2016.
  15. Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016 Aug;51(8):751-767. doi: 10.1007/s00535-016-1227-8. PMID: 27325300
  16. Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr;35(7):745-767. doi: 10.1111/j.1365-2036.2012.05011.x. PMID: 22356640
  17. Wiśniowska B, Tylutki Z, Wyszogrodzka G, et al. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016 Mar 10;17:12. doi: 10.1186/s40360-016-0053-1. Accessed 27 Dec 2016. PMID: 26960809
  18. Wolfe MM. Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders. UpToDate. https://www.uptodate.com/. 02 Jun 2016. Accessed 27 Dec 2016.
  19. Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. 2016 Sep;65(9):1402-1415. doi: 10.1136/gutjnl-2016-311715. PMID: 27261337
  20. Hunt R, Armstrong D, Katelaris P, et al. World Gastroenterology Organisation global guidelines: GERD global perspective on gastroesophageal reflux disease. J Clin Gastroenterol. 2017 Jul;51(6):467-478. doi: 10.1097/MCG.0000000000000854. PMID: 28591069
  21. Koop H. Medical therapy of gastroesophageal reflux disease beyond proton pump inhibitors: where are we heading?. Visc Med. 2018 Apr;34(2):110-115. doi: 10.1159/000486692. PMID: 29888239
  22. Niikura R, Yamada A, Hirata Y, et al. Efficacy of vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant non-erosive reflux disease. Intern Med. 2018 Sep;57(17):2443-2450. doi: 10.2169/internalmedicine.0492-17. PMID: 29607951
  23. Oshima T, Miwa H. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related dieases. J Neurogastroenterol Motil. 2018 Jul;24(3):334-344. doi: 10.1056/jnm18029. PMID: 29739175
  24. Shinozaki S, Osawa H, Hayashi Y, et al. Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease. Biomed Rep. 2017 Sep;7(3):231-235. doi: 10.3892/br.2017.947. PMID: 28894571
  25. Vakil NB. Antiulcer medications: mechanism of action, pharmacology, and side effects. UpToDate. http://www.uptodate.com. 22 May 2018. Accessed 13 Dec 2018.
  26. MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective. Integr Pharm Res Pract. 2018 Jun;7:41-52. doi: 10.2147/IPRP.S142932. PMID: 29892570
  27. Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018 Jan;12(1):7-16. doi: 10.5009/gnl16615. PMID: 28427116
  28. Hojo M, Nagahara A, Hahm KB, et al. Management of gastroesophageal reflux disease in Asian countries: Results of a questionnaire survey. Digestion. 2020;101(1):66-79. doi: 10.1159/000504749. PMID: 31801133
  29. Young A, Kumar MA, Thota PN. GERD: a practical approach. Cleve Clin J Med. 2020 Apr;87(4):223-230. doi: 10.3949/ccjm.87a.19114. PMID: 32238378
  30. Fass R. Approach to refractory gastroesophageal reflux disease in adults. UpToDate. https://www.uptodate.com. 24 Jun 2020.
  31. Kahrilas PJ. Clinical manifestations and diagnosis of gastroesophageal reflux in adults. UpToDate. https://www.uptodate.com. 28 Jan 2020.
  32. Kahrilas PJ. Medical management of gastroesophageal reflux in adults. UpToDate. https://www.uptodate.com. 01 Apr 2020.
  33. Schwaitzberg SD. Surgical management of gastroesophageal reflux in adults. UpToDate. https://www.uptodate.com. 12 Feb 2020.
  34. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus. Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. PMID: 29437910
  35. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute Technical Review on the management of gastroesophageal reflux disease. Gastroenterology. 2008 Oct;135(4):1392-1413. doi: 10.1053/j.gastro.2008.08.044. PMID: 18801365
  36. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. 2008 Oct;135(4):1383-1391, 1391. e1-5. doi: 10.1053/j.gastro.2008.08.045. PMID: 18789939
  37. Richter JE, Friedenberg FK. Gastroesophageal reflux disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia, PA: Saunders, Elsevier; 2016. 733-754. :733-754.
Editor's Recommendations
Special Reports